FDA investigating deaths, hospitalizations caused by fake Ozempic: reports
The Food and Drug Administration is investigating several hospitalizations and deaths potentially linked to counterfeit semaglutide drugs, such as Ozempic, according to multiple reports. At least three Americans have been hospitalized after injecting themselves with suspected counterfeit products, CBS News reported. The hospitalizations under investigation are believed to be among 42 cases reported to the …